![](/img/cover-not-exists.png)
32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Manegold, Ch., Stahel, R., Mattson, K., Ricci, S., van Walree, N.C., Bergman, B., ten Bokkel Huinink, W.W.Volume:
18
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(97)89311-7
Date:
August, 1997
File:
PDF, 131 KB
english, 1997